EGFR and neoplasm: To verify that inhibition of EGFR activity affected the invasiveness of tumor cells, we performed detailed cell counts, which revealed less invasive cells in cortical areas within the EGFR-CD533 group compared to the control group (Fig. 6a, Fig. S6).